Stay updated on Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site software revision was updated from v3.6.0 to v3.6.2, indicating a minor release. No changes to the study details or visible page content are introduced.
    Difference
    0.1%
    Check dated 2026-06-26T19:49:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed and adds new help/navigation sections. The Intervention/Treatment label is updated, and the revision footer shows v3.6.0 compared to v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-12T16:20:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new platform release. The change does not alter the study details or visible content on the page.
    Difference
    0.1%
    Check dated 2026-06-05T11:35:47.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer build of the page's interface without changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:31:14.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page’s displayed software release/revision indicator was updated from v3.5.2 to v3.5.3, reflecting a website version change rather than any modification to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:17.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible content or functionality changes.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.